Last €1.57 EUR
Change Today 0.00 / 0.00%
Volume 3.0K
BIG1 On Other Exchanges
BIG1 is not on other exchanges.
As of 1:15 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

bio-gate ag (BIG1) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/4/13 - €2.50
52 Week Low
09/25/13 - €1.43
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO-GATE AG (BIG1)

Related News

No related news articles were found.

bio-gate ag (BIG1) Related Businessweek News

No Related Businessweek News Found

bio-gate ag (BIG1) Details

Bio-Gate AG, a medical technology company, provides silver technology to endow materials and products with antimicrobial properties. The company’s products include plasma coatings, such as HyProtect that provides protection for the surfaces of medical implants and instruments against bacterial contamination; It also offers antimicrobial agents that comprise MicroSilver BG-Med, which is made of pure metallic silver for medical technology applications; MicroSilver BG for cosmetic applications; and MicroSilver BG-Tec for hygiene-sensitive applications in industries and consumer goods. In addition, the company provides product development and product registration support services. Its products have applications in medical technology products, such as medical devices and packaging, orthopedics, wound care, catheters, cardiology, implants, and dental products; industrial applications comprising industrial systems, food technology, and transportation systems; consumer goods, including electronics, white goods, and textiles; and cosmetics consisting of skin care, and hygiene-sensitive applicators and dosing units. Bio-Gate AG is headquartered in Nuremberg, Germany.

bio-gate ag (BIG1) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bio-gate ag (BIG1) Key Developments

Bio Gate AG Announces Earnings Results for 2013

Bio Gate AG announced earnings results for 2013. For the year, the company’s net loss narrowed to EUR 1.5 million from a loss of EUR 2.2 million in 2012. The loss before interest, tax, depreciation and amortization (LBITDA) shrank to EUR 1.1 million from EUR 1.7 million. Revenue rose by nearly 10% to EUR 2.5 million from EUR 2.3 million as the company managed to cut costs at key divisions.

Bio-Gate AG, Annual General Meeting, May 23, 2014

Bio-Gate AG, Annual General Meeting, May 23, 2014.

Bio-Gate AG to Report First Half, 2013 Results on Aug 16, 2013

Bio-Gate AG announced that they will report first half, 2013 results on Aug 16, 2013


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIG1:GR €1.57 EUR 0.00

BIG1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIG1.
View Industry Companies

Industry Analysis


Industry Average

Valuation BIG1 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.5x
Price/Book 12.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-GATE AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at